| Irreversible electroporation: state of the art PGK Wagstaff, M Buijs, W van den Bos, DM de Bruin, PJ Zondervan, ... OncoTargets and therapy, 2437-2446, 2016 | 122 | 2016 |
| MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed … W van den Bos, DM de Bruin, A Van Randen, MRW Engelbrecht, ... European radiology 26, 2252-2260, 2016 | 95 | 2016 |
| Optical diagnostics for upper urinary tract urothelial cancer: technology, thresholds, and clinical applications MTJ Bus, DM de Bruin, DJ Faber, GM Kamphuis, PJ Zondervan, ... Journal of Endourology 29 (2), 113-123, 2015 | 72 | 2015 |
| The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol W Van den Bos, DM De Bruin, BG Muller, IM Varkarakis, AA Karagiannis, ... BMJ open 4 (10), e006382, 2014 | 69 | 2014 |
| The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients W Van den Bos, DM De Bruin, RR Jurhill, CD Savci-Heijink, BG Muller, ... World journal of urology 34, 657-664, 2016 | 67 | 2016 |
| Diagnostic dilemmas in patients with upper tract urothelial carcinoma J Baard, DM De Bruin, PJ Zondervan, G Kamphuis, J De La Rosette, ... Nature Reviews Urology 14 (3), 181-191, 2017 | 66 | 2017 |
| Histopathological outcomes after irreversible electroporation for prostate cancer: results of an ablate and resect study W Van Den Bos, RR Jurhill, DM De Bruin, CD Savci-Heijink, AW Postema, ... The Journal of urology 196 (2), 552-559, 2016 | 54 | 2016 |
| Optical coherence tomography as a tool for in vivo staging and grading of upper urinary tract urothelial carcinoma: a study of diagnostic accuracy MTJ Bus, DM De Bruin, DJ Faber, GM Kamphuis, PJ Zondervan, ... The Journal of urology 196 (6), 1749-1755, 2016 | 53 | 2016 |
| Irreversible electroporation of the porcine kidney: temperature development and distribution PGK Wagstaff, DM de Bruin, W van den Bos, A Ingels, MJC van Gemert, ... Urologic Oncology: Seminars and Original Investigations 33 (4), 168. e1-168. e7, 2015 | 53 | 2015 |
| Thermal ablation in renal cell carcinoma management: a comprehensive review P Wagstaff, A Ingels, P Zondervan, JJ de La Rosette, MP Laguna Current opinion in urology 24 (5), 474-482, 2014 | 46 | 2014 |
| Histopathology: ditch the slides, because digital and 3D are on show I Jansen, M Lucas, CD Savci-Heijink, SL Meijer, HA Marquering, ... World journal of urology 36, 549-555, 2018 | 39 | 2018 |
| Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomography BG Muller, DM de Bruin, W Van den Bos, MJ Brandt, JF Velu, MTJ Bus, ... Journal of Medical Imaging 2 (3), 037501-037501, 2015 | 37 | 2015 |
| Cryoablation of small kidney tumors PJ Zondervan, M Buijs, JJ De La Rosette, O Van Delden, K Van Lienden, ... International journal of surgery 36, 533-540, 2016 | 35 | 2016 |
| Prostate cancer diagnosis by optical coherence tomography: First results from a needle based optical platform for tissue sampling BG Muller, DM de Bruin, MJ Brandt, W van den Bos, S van Huystee, ... Journal of biophotonics 9 (5), 490-498, 2016 | 34 | 2016 |
| The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol PGK Wagstaff, DM de Bruin, PJ Zondervan, CD Savci Heijink, ... BMC cancer 15, 1-7, 2015 | 34 | 2015 |
| Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal … A Ingels, M Hew, F Algaba, OJ de Boer, RJA van Moorselaar, ... World journal of urology 35, 81-87, 2017 | 33 | 2017 |
| Efficacy, safety, and biomarker analysis of neoadjuvant avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after … A Bex, Y Abu-Ghanem, JV Van Thienen, N Graafland, B Lagerveld, ... Journal of Clinical Oncology 40 (6_suppl), 289-289, 2022 | 29 | 2022 |
| A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX) A Bex, JV Van Thienen, M Schrier, N Graafland, T Kuusk, K Hendricksen, ... Future Oncology 15 (19), 2203-2209, 2019 | 27 | 2019 |
| Renal biopsies performed before versus during ablation of T1 renal tumors: implications for prevention of overtreatment and follow-up CV Widdershoven, BM Aarts, PJ Zondervan, MMEL Henderickx, ... Abdominal Radiology 46, 373-379, 2021 | 24 | 2021 |
| Available ablation energies to treat cT1 renal cell cancer: emerging technologies PJ Zondervan, M Buijs, DM De Bruin, OM van Delden, KP Van Lienden World Journal of Urology 37, 445-455, 2019 | 24 | 2019 |
Daniel Martijn de BruinAmsterdam University Medical Centers在 amsterdamumc.nl 的电子邮件经过验证
